PTN
PTN
AMEX · Biotechnology

Palatin Technologies Inc

$15.72
-0.33 (-2.06%)
As of Feb 8, 2:23 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -15.6% upside
Low Target $11.80
Average Target $13.27
High Target $20.48
Current Price $15.72
Current
$15.72
Target
$13.27
$11.80 $13.27 avg $20.48
Scenario Analysis
Bear Case
$11.80
-24.9%
Low target
Base Case
$13.27
-15.6%
Avg target
Bull Case
$20.48
+30.3%
High target
Risk/Reward
1.2x
Balanced
Price in Context
52-Week High
$15.27
2.9% from high
52-Week Low
$9.13
+72.2% from low
Target vs 52W High
$13.27
-13.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%